Extraordinary general meeting November 28 2018

Xspray Pharma – Notice EGM 2018[1]

EGM 2018 Fullmaktsformulär Eng – Proxy-form

XSpray Pharma – Terms and conditions of the warrants

The Board´s statement in accordance with Chapter 14 Section 8 of the Swedish Companies Act

Auditors Opinion under Chapter 14 Section 8 of the Swedish Companies Act

Annual general meeting May 14 2018

Notice to Annual General Meeting in Xspray Pharma AB (publ)

AGM_2018 – Proxy form

Extraordinary general meeting February 20 2018

Notice of extraordinary general meeting in Xspray Pharma AB (publ) February 20

The Board of Directors’ statement in accordance with Chapter 13 Section 6 of the Swedish Companies Act

Auditor’s opinion under Chapter 13 Section 6 the Companies Act (2005: 551) on the Board of Directorss statement of significant events for the period 2017-03-31 – 2018-01-30

The Board of Director’s of Xspray Pharma AB (publ) proposal for a resolution on a directed issue of shares

Proxy form